List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 43 studies with search of: Open Studies | "Mesothelioma"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
2 Recruiting Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin)
3 Recruiting An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Condition: Mesothelioma
Interventions: Drug: MORAb-009;   Drug: Premetrexed;   Drug: Cisplatin
4 Recruiting Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib;   Procedure: quality-of-life assessment
5 Recruiting Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma;   Metastatic Cancer
Interventions: Other: talc;   Procedure: therapeutic thoracoscopic surgery;   Procedure: therapeutic thoracoscopy;   Procedure: therapeutic videothoracoscopy
6 Recruiting Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib;   Drug: cisplatin
7 Not yet recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cediranib maleate;   Drug: cisplatin;   Drug: pemetrexed disodium;   Other: placebo
8 Recruiting AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Condition: Malignant Mesothelioma
Interventions: Drug: cediranib maleate;   Other: laboratory biomarker analysis
9 Recruiting Tomotherapy Treatment for Mesothelioma
Condition: Mesothelioma
Intervention: Procedure: Tomotherapy
10 Recruiting Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: pemetrexed disodium;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
11 Recruiting Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery
Condition: Malignant Mesothelioma
Interventions: Biological: SS1(dsFv)-PE38 immunotoxin;   Drug: cisplatin;   Drug: pemetrexed disodium;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: pharmacological study;   Procedure: quality-of-life assessment
12 Recruiting Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: bevacizumab;   Drug: cisplatin;   Drug: pemetrexed
13 Recruiting Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
Conditions: Malignant Mesothelioma;   Pulmonary Complications
Interventions: Genetic: microarray analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
14 Recruiting Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
Condition: Malignant Mesothelioma
Interventions: Dietary Supplement: vitamin B12;   Drug: cisplatin;   Drug: pemetrexed disodium;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Recruiting Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
Conditions: Lung Cancer;   Mesothelioma
Intervention:
16 Recruiting Suberoylanilide Hydroxamic Acid Vorinostat, MK0683 Versus Placebo in Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma;   Lung Cancer
Interventions: Drug: Comparator: Suberoylanilide Hydroxamic Acid (Vorinostat, MK0683);   Drug: Comparator: Placebo
17 Recruiting Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Mediastinal or Chest Wall Neoplasms, or Lung Metastases From Cancers of Non-Thoracic Origin
Conditions: Esophageal Cancer;   Lung Cancer;   Malignant Mesothelioma;   Metastatic Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Procedure: bronchoscopy;   Procedure: endoscopic biopsy;   Procedure: needle biopsy
18 Recruiting Dasatinib in Resectable Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: Dasatinib
19 Recruiting Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Procedure: Extrapleural pneumonectomy (EPP), Pleurectomy/Decortication;   Drug: cisplatin;   Drug: gemcitabine;   Drug: amifostine;   Drug: sodium thiosulfate
20 Recruiting Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)
Conditions: Malignant Pleural Mesothelioma;   MPM;   Solid Tumors
Interventions: Drug: pemetrexed, cisplatin and CBP501;   Drug: pemetrexed and cisplatin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services